361457-34-3 Usage
Chemical Structure
1H-Benzimidazole-5-methanol, 2-phenylis a chemical compound with a benzimidazole ring and a phenyl group attached to the 2-position.
Physical Appearance
It is a white to off-white crystalline powder.
Usage
Commonly used as a building block for the synthesis of various pharmaceuticals and agrochemicals.
Anti-cancer
Has been studied for its potential anti-cancer properties.
Anti-inflammatory
Has been studied for its potential anti-inflammatory properties.
Anti-microbial
Has been studied for its potential anti-microbial properties.
Additional Activity
Exhibits antioxidant activity.
Research
Being researched for its potential use in the development of new drugs for the treatment of various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 361457-34-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,1,4,5 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 361457-34:
(8*3)+(7*6)+(6*1)+(5*4)+(4*5)+(3*7)+(2*3)+(1*4)=143
143 % 10 = 3
So 361457-34-3 is a valid CAS Registry Number.
361457-34-3Relevant academic research and scientific papers
BENZIMIDAZOL DERIVATIVES FOR TREATING FILOVIRUS INFECTION
-
Page/Page column 22, (2018/04/13)
The present invention relates to compounds comprising a benzimidazole scaffold, and the use of such compounds for the treatment of viral diseases. The invention also relates to pharmaceutical compositions comprising said compounds as an active ingredient. In particular the compounds of the invention comprising a benzimidazole scaffold are used for the treatment of filoviruses or retroviruses, and preferably for the treatment of Ebola virus or HIV virus.
THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS
-
Page/Page column 96, (2008/06/13)
Invented is a method of inhibiting the activity/function of PI3 kinases using substituted thiazolones. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, ne
